Hi everyone,
I had recurrence at Christmas, two thirds of the way through Cisplatin and Gemcitabine, so I am now platinum resistant and lost my chance to get a PARP inhibitor through the CDF.
But, lucky timing, my recurrence coincided with the OCTOVA Trial being opened up to BRCA negative women. This small trial has 3 arms: a) Taxol, b) Olaparib and c) Olaparib and Cediranib. I am 6 days into arm c. This is also a crossover trial which means that if you recur on the Taxol arm while on the trial you get offered Olaparib.
I think this is the best chance at a PARP for platinum resistant women.
I hope this helps some of you look at other options.
Best wishes,
Louise